“The U.S. Food and Drug Administration today approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD) in adult patients who have initiated treatment with a transmucosal (absorbed through mucus membrane) buprenorphine-containing product. It is indicated for patients that have been on a stable dose of buprenorphine treatment for a minimum of seven days.
Buprenorphine for the treatment of OUD is currently approved to administer as a tablet or film that dissolves in the mouth, or as an implant. Sublocade provides a new treatment option for patients in recovery who may value the benefits of a once-monthly injection compared to other forms of buprenorphine, such as reducing the burden of taking medication daily as prescribed (medical adherence). An independent FDA advisory committee supported the approval of Sublocade at a meeting held last month.”
Source: FDA.gov – November 30, 2017
See related article: The FDA Just Approved A New Injection For Treating Opioid Addiction. Will Drug Courts Actually Let Defendants Take It? Available at: https://psmag.com/news/fda-approved-new-injection-for-treating-opioid-addiction
“On Nov. 18, a 32-year-old Gaylord woman was arrested after admitting to taking liquid methadone prior to driving.
She was charged with operating a vehicle while intoxicated — her second offense on the charge. If she was found guilty of the charge, it could result in a $200 to $1,000 fine, a $1,000 driver responsibility fee, five days to a year in jail and the revocation of her license for a minimum of a year.
So, is it safe to drive on methadone, even with a prescription? Is it legal?
The answer depends on a number of variables, but the crux of it boils down to this: Medical research has shown that methadone, when taken properly, does not affect driving, but under Michigan law, there are still ways in which a person can face legal consequences for driving on it.”
Source: PetoskeyNews.com – November 30, 2017
“The Justice Department on Wednesday said it is stepping up enforcement efforts to combat the opioid crisis.
Attorney General Jeff Sessions announced that the agency will dedicate $12 million in grants to help police target illegal manufacturers and dealers of prescription opioids, heroin and methamphetamine.
The department is also directing U.S. attorneys around the country to designate an “opioid coordinator” for each office, and the Drug Enforcement Agency will open a new field division in Louisville to cover Kentucky, Tennessee and West Virginia, where communities have suffered particularly high rates of opioid addiction.
Source: USNews.com – November 29, 2017
“A cross-section of opioid prescribers that typically do not prescribe large volumes of opioids, including primary care physicians, surgeons and non-physician health care providers, frequently prescribe opioids to high-risk patients, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health.
The findings suggest that high-volume prescribers, including “pill mill” doctors, should not be the sole focus of public health efforts to curb the opioid abuse epidemic. The study also found that “opioid shoppers,” patients who obtain prescriptions from multiple doctors and pharmacies, are much less common than other high-risk patient groups, suggesting why policy solutions focused on these patients have not yielded larger reductions in opioid overdoses.”
Source: MedicalExpress.com – November 29, 2017
“A new study finds that over 60 percent of individuals who died from an opioid overdose had been diagnosed with a chronic pain condition, and many had been diagnosed with a psychiatric disorder.
Researchers at Columbia University Medical Center reviewed more than 13,000 overdose deaths with the study the first to determine the proportion of those who died of an opioid overdose with chronic pain.
The analysis is timely as according to the US Centers for Disease Control, the number of opioid-related deaths has quadrupled, from 8,048 in 1999 to 33,091 in 2015.
The findings underscore the importance of providing substance use treatment services in conjunction with behavioral interventions for people with chronic pain.”
The study, “Service Use Preceding Opioid-Related Fatality,” appears online in the American Journal of Psychiatry.
Source: PsychCentral.com – November 29, 2017
A team of experts dismantle myths surrounding medication-assisted treatment, detox and addiction.
It’s 2017, but there’s still plenty of ignorance to go around. Namely, when it comes to discussing and understanding substance use disorders, long-held beliefs about these issues often come from a place of fear and prejudice.
In a new report by the Cincinnati Enquirer, experts in the field of substance use disorder and mental health take on four common myths about addiction:
- Myth 1: Addiction is not a disease.
- Myth 2: If someone addicted to heroin wants to stop using, they should just detox.
- Myth 3: Using methadone or buprenorphine is just trading a drug for a drug.
- Myth 4: It’s their fault, or their parents’ fault, that they are addicted to heroin.
Read more at: https://www.thefix.com/four-addiction-myths-shattered
Source: TheFix.com – November 30, 2017